Know Cancer

or
forgot password

    • cancer clinical trials in rochester, MN

    • Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Breast Cancer, Cognitive/Functional Effects, Lung Cancer, Metastatic Cancer, Prostate Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors
    Mayo Clinic
    Rochester, Minnesota 55905
    Unspecified Adult Solid Tumor, Protocol Specific
    Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Brain and Central Nervous System Tumors
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    Mayo Clinic
    Rochester, Minnesota 55905
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)
    Mayo Clinic
    Rochester, Minnesota 55905
    Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic, Myelodysplastic Syndromes
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Stage I Endometrial Carcinoma, Stage IB Cervical Cancer, Stage II Endometrial Carcinoma, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage III Endometrial Carcinoma, Stage IVA Cervical Cancer
    Gliogene: Brain Tumor Linkage Study
    Mayo Clinic Rochester
    Rochester, Minnesota 55905
    Brain Tumor, Glioma
    Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation
    Mayo Clinic
    Rochester, Minnesota 55905
    Pneumonia, Idiopathic Pneumonia Syndrome
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Cognitive/Functional Effects, Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma
    Mayo Clinic
    Rochester, Minnesota 55905
    Multiple Myeloma and Plasma Cell Neoplasm
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Phase 1-2 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma
    Mayo Clinic
    Rochester, Minnesota 55905
    Pheochromocytoma, Paraganglioma
    Pazopanib in Treating Patients With Malignant Pleural Mesothelioma
    North Central Cancer Treatment Group
    Rochester, Minnesota 55905
    Advanced Malignant Mesothelioma, Localized Malignant Mesothelioma, Recurrent Malignant Mesothelioma
    A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia
    Mayo Clinic
    Rochester, Minnesota 55905
    Myelofibrosis With Myeloid Metaplasia, Myeloid Metaplasia, Myelofibrosis
    Bicalutamide in Treating Patients With Metastatic Breast Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Breast Cancer
    Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
    Mayo Clinic
    Rochester, Minnesota 55905
    Barrett Esophagus, Esophageal Cancer
    Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
    Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Mayo Clinic
    Rochester, Minnesota 55905
    Multiple Myeloma and Plasma Cell Neoplasm
    Zevalin-beam for Aggressive Lymphoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Non-Hodgkin's Lymphoma
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors
    Mayo Clinic - Rochester
    Rochester, Minnesota 55905
    Advanced Neuroendocrine Tumors
    Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma
    Mayo Clinic - Rochester
    Rochester, Minnesota 55905
    Multiple Myeloma
    Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
    Mayo Clinic
    Rochester, Minnesota 55905
    HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Mayo Clinic
    Rochester, Minnesota 55905
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Mayo Clinic
    Rochester, Minnesota 55905
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia
    Mayo Clinic
    Rochester, Minnesota 55905
    Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myelogenous Leukemia (AML)
    Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma
    Mayo Clinic Rochester
    Rochester, Minnesota 55905
    Multiple Myeloma
    Lapatinib and Trastuzumab With or Without Endocrine Therapy
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Breast Cancer
    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Brain and Central Nervous System Tumors
    CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis
    Mayo Clinic
    Rochester, Minnesota 55905
    Multiple Myeloma and Plasma Cell Neoplasm
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Lung Cancer
    Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Endoscopic Mucosal Resection (EMR) in Barrett's Esophagus
    Mayo Clinic
    Rochester, Minnesota 55905
    Barrett's Esophagus, Early Esophageal Adenocarcinoma
    The Effect of Ablation Therapy on Barrett's Esophagus
    Mayo Clinic
    Rochester, Minnesota 55905
    Barrett's Esophagus, Early Esophageal Adenocarcinoma
    Biomarkers in Phototherapy of Barrett's Esophagus
    Mayo Clinic Rochester
    Rochester, Minnesota 55905
    Barrett's Esophagus, High Grade Dysplasia
    Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders
    Mayo Clinic
    Rochester, Minnesota 55905
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Hematopoietic/Lymphoid Cancer, Philadelphia Chromosome Negative Chronic Myelogenous Leukemia, Polycythemia Vera, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes
    Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Lymphedema, Musculoskeletal Complications, Radiation Fibrosis, Radiation Toxicity, Sarcoma
    Comparison of MRI and Molecular Breast Imaging in Breast Diagnostic Evaluation
    Mayo Clinic
    Rochester, Minnesota 55905
    Breast Cancer
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Mayo Clinic
    Rochester, Minnesota 55905
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma